Submission Details

Submitter:

Classification:
Moderate
GENCC:100003
Gene:
Disease:
cerebellar ataxia
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
01/15/2024
Evidence/Notes:

CA8 was first reported in relation to autosomal recessive cerebellar ataxia in 2009 (Turkmen et al., PMID: 19461874). CA8-related cerebellar ataxia is characterized by features of cerebellar ataxia such as wide-based or quadrupedal gait, intention tremor, dysarthria, cerebellar atrophy, and developmental delay with or without cognitive delay (PMIDs: 19461874, 21812104, 21937992, 27217339, 31693170, 32808436). Six variants (5 missense and 1 truncating) that have been reported in 12 individuals (6 probands) in 6 publications (PMIDs: 19461874, 21812104, 21937992, 27217339, 31693170, 32808436) are included in this curation. The mechanism of pathogenicity appears to be loss of function.

This gene-disease relationship is also supported by experimental evidence. The ataxic mouse model 'Rigoletto' (rig) carries a 19-bp deletion in Car8, the mouse homolog of CA8. Studies of cerebellar Purkinje cells in these mice showed decreased spontaneous excitatory transmission with a reportedly lower number of functional synapses. Mutants also showed abnormalities of the extension of climbing fibers to distal Purkinje cell dendrites, of parallel fibers and dendritic spines (including free spines that did not form normal synapses), and multiple synaptic varicosities. The authors concluded that Car8 plays a critical role in synaptogenesis and/or maintenance of proper synaptic morphology and function in the cerebellum (PMID: 17376701). Expression studies also indicated specific expression of CAR8 in cerebellar Purkinje cells and minimal to absent expression in the spinal cord and cerebral cortex (PMIDs: 16118194, 31693170).

In summary, there is moderate evidence supporting the relationship between CA8 and autosomal recessive cerebellar ataxia. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Autism and Intellectual Disability Gene Curation Expert Panel on January 16, 2024 (SOP Version 10).

CA8 was first reported in relation to autosomal recessive cerebellar ataxia in 2009 (Turkmen et al., PMID: 19461874). CA8-related cerebellar ataxia is characterized by features of cerebellar ataxia such as wide-based or quadrupedal gait, intention tremor, dysarthria, cerebellar atrophy, and developmental delay with or without cognitive delay (PMIDs: 19461874, 21812104, 21937992, 27217339, 31693170, 32808436). Six variants (5 missense and 1 truncating) that have been reported in 12 individuals (6 probands) in 6 publications (PMIDs: 19461874, 21812104, 21937992, 27217339, 31693170, 32808436) are included in this curation. The mechanism of pathogenicity appears to be loss of function.

This gene-disease relationship is also supported by experimental evidence. The ataxic mouse model 'Rigoletto' (rig) carries a 19-bp deletion in Car8, the mouse homolog of CA8. Studies of cerebellar Purkinje cells in these mice showed decreased spontaneous excitatory transmission with a reportedly lower number of functional synapses. Mutants also showed abnormalities of the extension of climbing fibers to distal Purkinje cell dendrites, of parallel fibers and dendritic spines (including free spines that did not form normal synapses), and multiple synaptic varicosities. The authors concluded that Car8 plays a critical role in synaptogenesis and/or maintenance of proper synaptic morphology and function in the cerebellum (PMID: 17376701). Expression studies also indicated specific expression of CAR8 in cerebellar Purkinje cells and minimal to absent expression in the spinal cord and cerebral cortex (PMIDs: 16118194, 31693170).

In summary, there is moderate evidence supporting the relationship between CA8 and autosomal recessive cerebellar ataxia. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on January 16, 2024 (SOP Version 10).

PubMed IDs:
16118194 17376701 19461874 21812104 21937992 27217339 31199789 31693170 32808436
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.